Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
Casulo C, Dixon JG, Le-Rademacher J, Hoster E, Hochster HS, Hiddemann W, Marcus R, Kimby E, Herold M, Sebban C, Gyan E, Foon K, Nielsen T, Vitolo U, Salles GA, Shi Q, Flowers CR.
Casulo C, et al. Among authors: foon k.
Blood. 2022 Mar 17;139(11):1684-1693. doi: 10.1182/blood.2020010263.
Blood. 2022.
PMID: 34614146
Free PMC article.